Index of opportunity and company fields populated by our integrated databases
Overview
Inpart Deal provides integrated data from Cortellis, Evaluate Pharma, Pharmaprojects, and Inpart Data. This data materializes in the autofill for opportunity creation and in the detailed profiles in the Database panel on the opportunity and company pages.
This article lists all fields that are populated by these databases.
To learn how to leverage our database integrations, see Enrich your opportunity and company information with Cortellis, Pharmaprojects, Evaluate Pharma & Inpart Data profiles.
Autofill
Asset fields
Important note: The field names below are the default names provided by the application; they may differ from what has been customized on your Administration page.
| Field name | Inpart Data |
Cortellis |
Pharmaprojects |
| Clinical indications | ✓ |
✓ |
✓ |
| Company | ✓ | ✓ | ✓ |
| Description | - | ✓ | - |
| Development phase | ✓ |
✓ |
✓ |
| Drug type | ✓ |
✓ |
✓ |
| Mechanism of action | ✓ |
✓ |
✓ |
| Name | ✓ |
✓ |
✓ |
| Technologies | ✓ |
✓ |
✓ |
| Therapeutic areas | ✓ |
✓ |
✓ |
Company fields
| Field name | Inpart Data |
Cortellis |
Pharmaprojects |
| Address | ✓ |
✓ |
✓ |
| City | ✓ |
✓ |
✓ |
| Country | ✓ |
✓ |
✓ |
| Description | ✓ |
✓ |
✓ |
| Name | ✓ |
✓ |
✓ |
| State/province | - |
✓ |
✓ |
| Type | ✓ |
✓ |
✓ |
| URL | ✓ |
✓ |
✓ |
| Zipcode | ✓ |
✓ |
✓ |
Database panel
Opportunity pages
| Field name | Inpart Data |
Evaluate Pharma |
Evaluate Pharma |
Overview | |||
| Annual sales | - |
✓ |
✓ |
| Comment | - |
✓ |
✓ |
| Company | ✓ |
✓ |
✓ |
| Description | ✓ |
- |
- |
| Development phase and Clinical indication | ✓ |
- |
- |
| Indication summary (Indication, Dev. phase, status) | - |
✓ |
✓ |
| Market status (Region, Status, Current phase) | - |
✓ |
✓ |
| Mechanism of action | ✓ |
✓ |
✓ |
| Next milestones | ✓ |
- |
- |
| Patent expiry date | - |
✓ |
✓ |
| Predictive annual sales | - |
- |
✓ |
| Proprietary level | - |
✓ |
✓ |
| Publications | ✓ |
- |
- |
| Route of administration | ✓ |
- |
- |
| Targets | ✓ |
- |
- |
| Technology(s) | ✓ |
✓ |
✓ |
| Technology category | - |
✓ |
✓ |
| Therapeutic category | - |
✓ |
✓ |
| Therapeutic subcategory | - |
✓ |
✓ |
| Type | ✓ |
- |
- |
Deals | |||
| Company | - |
- |
✓ |
| Company product name | - |
- |
✓ |
| Deal date | - |
- |
✓ |
| Deal partner/Product source | - |
- |
✓ |
| Deal type | - |
- |
✓ |
| Deal value ($m) | - |
- |
✓ |
| Product | - |
- |
✓ |
| Status of deal date | - |
- |
✓ |
| Upfront payment ($m) | - |
- |
✓ |
Indication-level predictions | |||
| Benchmarck PTRS (%) | - |
- |
✓ |
| EMA approval date | - |
- |
✓ |
| FDA approval date | - |
- |
✓ |
| Upcoming milestones Dev. phase, Date |
- |
- |
✓ |
Company pages
| Field name | Inpart Data |
Evaluate Pharma |
Evaluate Pharma |
General information | |||
| City | ✓ |
✓ |
✓ |
| Company type | ✓ |
- |
- |
| Country | ✓ |
✓ |
✓ |
| Date | - |
✓ |
✓ |
| Detailed pipeline in Evaluate Pharma (link) | - |
✓ |
✓ |
| Market status | ✓ |
✓ |
✓ |
| URL | ✓ |
- |
- |
Overview | |||
| Description | ✓ |
- |
- |
| Former | ✓ |
- |
- |
| Summary | ✓ |
- |
- |
Company financials | |||
| Funding round | ✓ |
- |
- |
| Investors | ✓ |
- |
- |
| Market capitalization (m$) | ✓ |
- |
- |
| Number of employees | ✓ |
- |
- |
| Secured funds (m$) | ✓ |
- |
- |
R&D projets | |||
| By development phase | - |
✓ |
✓ |
| By technology | - |
✓ |
✓ |
| By therapeutic area | - |
✓ |
✓ |
Deals | |||
| Deal name, type, date | - |
- |
✓ |
Consensus forecast sales | |||
| By therapeutic area | - |
- |
✓ |